Semaglutide 2.4 mg for Obese Patients with MASH: A Cost-Effectiveness Analysis from the Italian NHS Perspective.
Saved in:
| Title: | Semaglutide 2.4 mg for Obese Patients with MASH: A Cost-Effectiveness Analysis from the Italian NHS Perspective. |
|---|---|
| Authors: | Torre E; Diabetology and Metabolic Diseases Unit, ASL3 Genoa, Genoa, Italy., Di Matteo S; Center of Research, SAVE Studi - Health Economics and Outcomes Research, Milan, Italy., Martinotti C; Center of Research, SAVE Studi - Health Economics and Outcomes Research, Milan, Italy., Bruno GM; Department of Drug Sciences, University of Pavia, Pavia, Italy., Cabrino A; Center of Research, SAVE Studi - Health Economics and Outcomes Research, Milan, Italy., Fogliati EL; Center of Research, SAVE Studi - Health Economics and Outcomes Research, Milan, Italy., Giusti A; Internal Medicine Unit, ASL3 Genoa, Genoa, Italy., Barbieri M; Otolaryngology Unit, ASL3 Genoa, Genoa, Italy., Bottaro LC; General Direction, ASL3 Genoa, Genoa, Italy., Colombo GL; Department of Drug Sciences, University of Pavia, Pavia, Italy. |
| Source: | ClinicoEconomics and outcomes research : CEOR [Clinicoecon Outcomes Res] 2026 May 01; Vol. 18, pp. 585328. Date of Electronic Publication: 2026 May 01 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101560564 Publication Model: eCollection Cited Medium: Print ISSN: 1178-6981 (Print) Linking ISSN: 11786981 NLM ISO Abbreviation: Clinicoecon Outcomes Res Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1178-6981 |
|---|---|
| DOI: | 10.2147/CEOR.S585328 |
